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ARTICLE
Development and diagnostic validation of the Brisbane Evidence-Based
Language Test
Alexia Rohdea,b, Suhail A. Doic, Linda Worrallb , Erin Godecked, Anna Farrelle, Robyn O’Halloranf ,
Molly McCrackenb, Nadine Lawsong, Rebecca Cremere and Andrew Wongh
aSpeech Pathology Department, Southern Cross University, Bilinga, Australia; bSpeech Pathology Department, The University of Queensland,
Brisbane, Australia; cDepartment of Population Medicine, Qatar University, Doha, Qatar; dDepartment of Speech Pathology, Edith Cowan
University, Joondalup, Australia; eDepartment of Speech Pathology, Royal Brisbane and Women’s Hospital, Brisbane, Australia; fDepartment of
Community and Clinical Allied Health, La Trobe University, Melbourne, Australia; gDepartment of Speech Pathology, Princess Alexandra
Hospital, Brisbane, Australia; hDepartment of Neurology, Royal Brisbane and Women’s Hospital, Brisbane, Australia
ABSTRACT
Purpose: To describe the development and determine the diagnostic accuracy of the Brisbane Evidence-
Based Language Test in detecting aphasia.
Methods: Consecutive acute stroke admissions (n¼ 100; mean ¼ 66.49y) participated in a single (asses-
sor) blinded cross-sectional study. Index assessment was the 45min Brisbane Evidence-Based Language
Test. The Brisbane Evidence-Based Language Test is further divided into four 15–25min Short Tests: two
Foundation Tests (severe impairment), Standard (moderate) and High Level Test (mild). Independent refer-
ence standard included the Language Screening Test, Aphasia Screening Test, Comprehensive Aphasia
Test and/or Measure for Cognitive-Linguistic Abilities, treating team diagnosis and aphasia referral post-
ward discharge.
Results: Brisbane Evidence-Based Language Test cut-off score of 157 demonstrated 80.8% (LRþ¼10.9)
sensitivity and 92.6% (LR¼0.21) specificity. All Short Tests reported specificities of 92.6%. Foundation
Tests I (cut-off 61) and II (cut-off 51) reported lower sensitivity (57.5%) given their focus on severe
conditions. The Standard (cut-off 90) and High Level Test (cut-off 78) reported sensitivities of 72.6%.
Conclusion: The Brisbane Evidence-Based Language Test is a sensitive assessment of aphasia.
Diagnostically, the High Level Test recorded the highest psychometric capabilities of the Short Tests,
equivalent to the full Brisbane Evidence-Based Language Test. The test is available for download from
brisbanetest.org.
 IMPLICATIONS FOR REHABILITATION
 Aphasia is a debilitating condition and accurate identification of language disorders is important
in healthcare.
 Language assessment is complex and the accuracy of assessment procedures is dependent upon a
variety of factors.
 The Brisbane Evidence-Based Language Test is a new evidence-based language test specifically
designed to adapt to varying patient need, clinical contexts and co-occurring conditions.
 In this cross-sectional validation study, the Brisbane Evidence-Based Language Test was found to be
a sensitive measure for identifying aphasia in stroke.
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Introduction
Accurate identification of acquired language disorders (aphasia) is
important in healthcare. Clinical assessment of language however
is complex and multifaceted [1,2] and the accuracy of assessment
procedures is dependent upon a number of factors. Performance
on language tasks may be easily impacted by multiple other clin-
ical elements which can spuriously influence the accuracy of test
scores [2,3]. Co-occurring apraxia of speech or dysarthria may
influence verbal language performance and lead to false positives
on assessment tasks [3]. Visual deficits such as hemianopia or
neglect may interfere with the perception of written language
stimulus or the naming of pictures [3,4] and motor limb impair-
ments such as hemiparesis may impact on writing legibility [5].
Additional factors such as patient fatigue, medical instability and
the pressured demands of different clinical contexts also require
language testing to be time-efficient, user-friendly and adaptable
to the varying needs of the testing environment [2].
A wide range of language tests currently exist. Brief aphasia
screening tests such as the Frenchay Aphasia Screening Test
(FAST) [6], Language Screening Test (LAST) [7] and ScreeLing [8]
aim to provide a fast, efficient gauge of language functioning.
These “non-specialist” screeners are intended for use by multiple
professions and focus on efficiency and brevity in aphasia
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screening. Such tests however gauge functioning through a nar-
row range of language tasks, do not assess language ability across
the severity spectrum from severe to mild, and at times omit
assessment of core language domains such as reading and/or
writing [7]. As a result, any deficits within any these areas may
be missed.
Comprehensive language tests such as the Western Aphasia
Battery-Revised (WAB-R) [3], Comprehensive Aphasia Test (CAT) [9]
and Boston Diagnostic Aphasia Examination (BDAE) [10] provide a
thorough evaluation of language across the domains. Such meas-
ures however take up to 1-2 h to administer and have been
reported to be too cumbersome for use in certain settings (e.g.,
acute hospital sessions which typically last 30min) [2,11]. Other,
more time-efficient speech pathology measures such as the Acute
Aphasia Screening Protocol [12] and WAB-R Bedside [3] are widely
used in practice. However, surprisingly, systematic reviews of the
literature have failed to find any published studies reporting these
tests’ validation in stroke patients with and without apha-
sia [13,14].
The complexity of clinical language evaluations highlights the
need for an evidence-based, adaptable, time-efficient yet compre-
hensive language test. The Brisbane EBLT is a new language test
created to address this need. The test has been developed from
Evidence-Based Principles (EBP) [15] and is available in five test
versions specifically developed to accurately assess language
while adjusting to patient need, the clinical context and co-occur-
ring conditions. The aim of this study is to report on the develop-
ment and diagnostic validation of the Brisbane EBLT in identifying
aphasia in stroke populations.
Materials and methods
Study design and participants
Diagnostic accuracy was examined in a single (assessor) blinded
cross-sectional study of 100 consecutive acute stroke admissions
at two large tertiary hospitals in Brisbane, Australia. A priori sam-
ple size calculations revealed 98 patients were required to yield a
10% width of a 2-sided 95% CI with a conservative estimate of
50% disease prevalence [16] (estimates of aphasia in left-hemi-
sphere brain damage reported to be 55.1%) [17]. The project was
granted university and health service committee ethics approval
and aims to comply with recognised Standards for Reporting
Diagnostic Accuracy (STARD) [18]. The STARD statement is an
EQUATOR network guideline (Enhancing the QUAlity and
Transparency Of health Research) of widely accepted criteria for
the rigorous reporting of sample selection, study design and stat-
istical analysis in diagnostic accuracy research [18].
Target condition
The target disorder was defined as impaired language functioning
from severe to mild deficits within any language domain (verbal
expression, comprehension, reading, writing, and gesture) result-
ing from ischaemic or haemorrhagic stroke.
Inclusion/exclusion criteria
All admitted stroke patients were screened for eligibility within
2 days of hospital admission. Eligible patients were those admitted
for stroke management and deemed sufficiently medically stable
to undergo language assessment if the following were met: sus-
tained level of consciousness for >10min (cognitive functioning
was pragmatically assessed based on a patient’s ability to
participate in, engage with and complete the required language
tasks); absence of any precluding acute medical condition as per
treating medical team; aged >14 years; native-level English lan-
guage ability, and with confirmed stroke site of lesion (as deter-
mined by acute medical CT/MRI report) within the left frontal,
parietal, temporal, occipital, limbic or insular lobes, basal ganglia
(caudiate nucleus, putamen, globus pallidus, substantia nigra,
nucleus accumbens, and subthalamic nucleus), internal capsule,
and thalamus (including thalamic nuclei). To optimise test external
validity, the presence of common post-stroke non-language but
communication-related conditions (affecting vision, hearing,
speaking, or writing) such as hemianopia, hemiparesis, dysarthria
or apraxia of speech was not used as an exclusionary criterion.
For these patients, the presence of these co-occurring conditions
was noted, and language test items severely affected by these
conditions (such that they were uninterpretable) were recorded as
missing data. Patients with subarachnoid haemorrhage or lesions
isolated to the right cerebral hemisphere, right subcortical regions
or midbrain, or below (as identified by acute medical CT/MRI
report) were excluded [19].
Assessments
Brisbane EBLT test development
The Brisbane EBLT is a new language test conceived and created
by the first author, Alexia Rohde. The first phase of test develop-
ment involved the construction of a large item bank of stimulus
items including both language tasks (e.g., repetition, reading
aloud, picture-word matching) and questions (e.g., picture naming
“what is this called?”). The aim of the item bank was to develop
as many new tasks and questions as possible for the new assess-
ment. This item bank was guided by the structure and content of
existing informal language measures (n¼ 44) which were col-
lected from clinicians via an email request sent through a profes-
sional speech pathology network. Based on these informal
measures, similar new tasks and questions were created which
formed the basis of the new test. These items were created to
assess language across all the domains of verbal expression, audi-
tory comprehension, gesture, reading and writing. Linguistic fac-
tors, such as word length, stimulus imageability and word
frequency were all incorporated into the test development pro-
cess. Tasks and questions were designed to assess language
across the severity spectrum, from simpler (e.g., picture matching
tasks) to complex high-level questions (e.g., synonyms “what is
one word that means the same as… ?”). Item bank tasks and
questions were categorised into a specific area (language domain
and difficulty level) to ensure each language area and severity of
language functioning was assessed.
At this phase in the test development, the item bank included
over 100 subtests and was far too lengthy for practical use. The
next phase involved the shortening of the item bank to a work-
able test length (50 subtests). Tasks and questions which were
ambiguous, too long, not practical, or difficult to score were elimi-
nated to leave only the most effective, efficient and easy-to-score
items within the final measure. During this phase each language
task and question underwent a rigorous process of piloting, feed-
back, revision and review based on the four principles of EBP [15]:
Clinician experience. A total of 108 clinicians provided feedback
on test items during the development process. Speech patholo-
gists provided feedback in a variety of settings including as part
of their attendance at a national conference, as part of focus-
groups and during one-to-one test administration sessions.
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During this time the test was a dynamic document that under-
went frequent revision and refinement. Speech pathologists
reviewed the new assessment and then provided feedback.
Changes to the test were then made and the test then underwent
further speech pathology review. The test became progressively
shorter as duplicate/similar, ambiguous and difficult-to-score tasks
and questions were excluded. This pattern was repeated until nil
new feedback on the document was obtained.
Clinical context. Piloting of the test in the acute hospital environ-
ment (n¼ 10 patients) led to the exclusion of test items too
lengthy or cumbersome for acute use. Subtests became short in
length (maximum of 5–6 tasks/questions) to ensure the test
moved quickly and swiftly across assessment areas. In the final
phase of test development, two speech pathology hospital
departments piloted the test in their clinical caseloads (n¼ 17
clinicians) and gave further feedback on test items.
Patient perspectives. Directly following administration, item bank
feedback from stroke patients and/or family members (n¼ 74)
was sought. Potential cultural bias was minimised with feedback
obtained from participants originating from the following English
speaking countries: USA, England, Australia, New Zealand,
Scotland, Canada, and South Africa. Any test items with reported
cultural bias (items unfamiliar to participants from any cultural
background) were excluded. The majority of patients (n¼ 57) had
positive/nil concerns with the new test (“I enjoyed it,” “Was what I
expected it,” “No worries,” etc.). Feedback relating to specific tasks
or questions was provided by three study participants/their family
members which was incorporated into the test development pro-
cess. For example, the parent of one study participant reported
that “Some task instructions were quite complex however the
tasks were low. Like the ‘semantic’ ones’.” For simpler items, it
was subsequently ensured that an example was always first com-
pleted by the administering clinician to demonstrate the type of
required response. Verbal understanding of the instructions is
therefore not needed.
Five of the study participants reported the test was “too long”
(n¼ 5), “too simplistic” (n¼ 5) or “too difficult” (n¼ 4). To minim-
ise patient fatigue, avoid patient exposure to test items consid-
ered too difficult or easy and replicate the typical length of
existing informal measures, the Brisbane EBLT was then subse-
quently also made available in four shorter versions (Short Tests).
Clinician experience, clinical context and patient feedback were all
instrumental in guiding the test development process. Only tasks
and questions meeting these rigorous EBP standards were
included in the final measure, the Brisbane EBLT.
Clinically relevant research. The final EBP principle is the focus of
this report which describes the diagnostic analysis of this
new test.
Brisbane EBLT
The above test development process resulted in the final meas-
ure, the Brisbane EBLT which is the full version of the assessment,
evaluating language in 49 subtests (45min) across the severity
spectrum (severe to mild) in the following language domains
(Table 1): verbal expression including repetition, automatic
speech, spontaneous speech (picture description), naming, audi-
tory comprehension, actions/gesture, reading, and writing. Certain
subtests require the use of two of each of the following everyday
objects: cup, spoon, pen and knife. An additional “Perceptual”
subtest examines abilities not requiring a verbal or written
response (e.g., object to picture matching) to allow assessment of
functioning when both verbal and written responses may be diffi-
cult (for example in situations when both severe apraxia of
speech may result in limited verbal expression and dominant-
hand hemiparesis may limit written responses). Large print/pic-
tures and the use of everyday objects as stimulus items assist to
accommodate visual co-occurring conditions (e.g., hemianopia).
Short, concise writing tasks (for example “Write ONE sentence
which contains ALL of these words in THIS order” requires only a
single sentence written response) minimise upper limb motor
fatigue associated with hemiparesis or non-dominant hand use.
The 49 Brisbane EBLT subtests and description of test items are
listed in Table 1.
Test administration and scoring
The Brisbane EBLT does not have a user’s manual. All information
required to use and administer the test is contained on the test
forms themselves and the Administration and Scoring Guidelines
form (brisbanetest.org). Question-specific administration and scor-
ing information is contained on the Brisbane EBLT test forms
whereas overall scoring guidelines are provided on the
Administration and Scoring Guidelines form. The same
Administration and Scoring Guidelines apply to all test versions.
Test administration is standardised. Each question is adminis-
tered by following the task instructions given above each ques-
tion. Prompting (e.g., the provision of an initial phoneme or
additional gestural cue) is not allowed. All tasks must be adminis-
tered according to the set instructions. One repetition of task
instructions is allowed without penalty for non-language related
difficulties in interpreting task instructions (e.g., hearing impair-
ment). This repetition has no influence on scoring (e.g., if the
patient answers correctly on the second (louder) repetition, the
response is still scored as correct).
Patient responses should be scored according to the first pur-
poseful response within the target modality (e.g., the first pur-
poseful attempt at a verbal response is scored, any prior
unrelated vocalisations are not scored). The most common
responses are provided on the test form. If an alternative yet cor-
rect response is given (other than those listed), as judged by the
administering clinician, this is still scored as correct. Scores are
not deducted for responses impacted by motor related output
deficits (e.g., phonetic distortions due to dysarthria or reduced
writing legibility due to hemiparesis) providing the target is still
interpretable. If the response is not interpretable (e.g., illegible
writing or unintelligible speech), these items are to be left blank
with a brief note reporting the reason for the lack of score. Non-
language related self-correction (e.g., attempts to neaten messy
writing due to hemiparesis) are not penalised (still scored as cor-
rect), however if any language-related self-corrections are evident
(e.g., self-correcting phonemic or semantic paraphasias), these are
scored incorrect. All Brisbane EBLT test forms and the
Administration and Scoring Guidelines are available from
brisbanetest.org.
Language reference standard
The reference standard diagnosis was based on five clinical fac-
tors; the results from a battery of published tests interpreted in
the context of four additional clinical factors [21]:
1. A composite language test score: All patients were first
administered the Language Screening Test (LAST) [7] a brief
(2min) “non-specialist” screening test which provided an ini-
tial gauge of language functioning and directed which com-
prehensive language battery would be most appropriate.
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Table 1. Brisbane EBLT subtests.
Subtest Task description Score Total
Perceptual
1. Copying Gestures “Copy what I’m doing” (e.g., point to nose). /2
2. Object to Object Matchinga “Which object matches with this?” (e.g., matching cups) /2
3. Demonstrating Object Usea “Show me how you would use these objects” (e.g., pen, writing). /2
4. Demonstrating Gestures
from Pictures
“Show me the action that goes with each picture”
(e.g., toothbrush).
/2
5. Object to Picture Matchinga “Match the object with the right picture” (e.g., spoon). /2
6. Picture to Picture Matching
(semantic links)
“Which of the bottom two pictures goes best with the middle
one?” (e.g., matching apple with banana)
/5 /15
Auditory comprehension
7. Yes/No Questions “Answer these questions” (e.g., Is it night time?) /12
8. Following Verbal Commands “I’d like you to do what I say” (1–4 stage commands). /8
9. Identifying Pictures by
Description
“Point to the… .” (e.g., boat). /6
10. Identifying Objects by Function “I would like you to point to some different body parts” (e.g.,
point to where you would wear a hat).
/2
11. Odd-one-out “Tell me, which one of these words is the odd one out or doesn’t
belong.” (4 words) “Why?”
/2
12. Complex Question “Answer these questions” (e.g., repeat these words in alphabetical
order (4 words)).
/6
13. Self-Reported Difficulty? “Do you think these last few questions are harder for your now
since you have had your stroke?”
Yes/No
14. Synonyms What is one word that means the same as… ?” (e.g.,
surprised/shocked).
/2 /38
Verbal expressionc
15. Automatic Speech “Count from 1 to 10.” /1
16. Sentence Completion “Finish what I say” (e.g., Boys and… ). /2
17. Personal/Orientation Questions “Tell me, what is?” (e.g., your name?) /6
18. Repetition “Repeat what I say” (3 words, 1 sentence). /4
19. Object Naminga “What is this called?” (e.g., knife). /2
20. Naming Actionsa “What do you call this action?” (e.g., drinking). /2
21. Picture Naming “Look at these pictures. What is this?” (e.g., car). /4
22. Naming Objects from
the Roomb
“What’s this called?” (e.g., pillow). /4
23. Naming Gestures “Tell me what action I’m doing” (e.g., salute). /2
24. Verbal Fluency – Animals “Name as many different animals as you can in 1minute.” /45d
24. Verbal Fluency – Words Starting
with F
“Name as many words starting with the letter “F” as you can
in 1minute.”
/35d
25. Picture Description “Look at this picture, it tells a story. Tell me what you see.”
(stimulus is the Cookie Theft Picture [10] and scoring based on
no. of content units produced) (scoring system adapted from
Yorkston & Beukelman [20]).
/16
26. Self-Reported Difficulty? “Did you find that task difficult?” Yes/No
27. Word Definitions “Tell me what these words mean. Explain the word as fully as you
can” (e.g., school).
/4
28. Similarities and Differences “Tell me what is similar and what is different about these things.” /2
29. Proverbs “Tell me, what does this saying mean?” /3 /132
Reading
30. Object to Word Matchinga “Match the object with the right word.” (e.g., spoon). /2
31. Single Word Reading “Read these words and then point to the body part” (e.g., ear). /2
32. Written Word to
Picture Matching
“Read each of these words aloud and then point to the right
picture” (e.g., diamond).
/6
33. Following Written Commands “Read this and then do what it says” (1–2 stage commands). /4
34. Sums “Solve these” (calculations). /2
35. Reading Aloud “Read this aloud” (sentence). /1
36. Medicine Label “Here is a medicine label” (e.g., How many tablets per day?) /3
37. High Level Sentence
Comprehension
“Read these instructions and answer the questions”
(complex questions).
/2
38. Self-Reported Difficulty? “Did you feel you had any difficulty reading and understanding
the words as you read?” (reading comprehension).
Yes/No
39. Delayed Recallc “Now, tell the exact story back to me.” (written paragraph recall). /21
40. Inference “What do you think really happened?” /1 /44
Writing
41. Drawing Completion “Look at this picture. Draw in the part that is missing.” /1
42. Simple Copying “Look at these. Copy them below.” /2
43. Functional Writing – Name “Write your full name here.” /2
44. Functional Writing – Address “Please fill in the form.” /3
45. Writing to Dictation “Write down what I say.” /6
46. Written Naming – Object “I’m going to point to something. Write down what it’s called”
(index finger.)
/1
(continued)
4 A. ROHDE ET AL.
Patients were then administered one of three longer compre-
hensive batteries, the Aphasia Screening Test (AST) [22] (LAST
scores  5/15), the Comprehensive Aphasia Test (CAT) [9]
(LAST scores of 5–15), or the Measure for Cognitive-Linguistic
Abilities (MCLA) [23] (LAST scores 10).
2. The treating clinician’s documented diagnosis,
3. Multidisciplinary report
4. Medical team report, and
5. Presence of referral for language services post-discharge
Reference diagnosis was based on a majority of clinical deter-
minants of 3 out of the five areas.
Procedure
Consecutive stroke admissions from 21 January to 15 December
2015 were reviewed for eligibility. Informed written consent was
obtained for all participants or an officially authorised next of kin.
Recruited participants completed the full 49 subtest Brisbane
EBLT and reference measure randomised in order. Brisbane EBLT
sections were also randomised for each participant. The assess-
ment procedure was single (assessor) blinded. Assessments were
administered as closely together as possible at the patient’s bed-
side or ward clinic room by two speech pathologists blinded to
the other’s test results. Study participants were not directly
informed of their aphasia diagnosis status as part of their partici-
pation in this study, however their diagnosis status likely would
have been disclosed by members of their treating multidisciplin-
ary care team as part of their routine acute stroke care.
Statistical analysis
Diagnostic analysis was completed using MedCalc v 13.3.3.0 and/
or Stata/IC 13.0. Diagnostic accuracy was calculated by comparing
Brisbane EBLT test scores against the binary (yes/no) reference
result to determine test sensitivity, specificity, positive (þLR), and
negative likelihood ratios (LR). Test discrimination against the
reference standard was determined using the area under (AUC)
the receiver operating characteristic (ROC) curve. Cut-off scores
for discriminating between patients with and without aphasia
were determined by evaluating the sensitivity and specificity esti-
mates at each cut-off threshold score.
Brisbane EBLT Short Tests
The Brisbane EBLT was administered to the 100 patients for the
purposes of data collection to allow for a full dataset of all 49
subtests of the Brisbane EBLT to be captured. However, at
45min in length this full test version of the Brisbane EBLT is
inappropriate for use in many contexts (e.g., routine acute hos-
pital bedside use) [2,11]. To replicate the <30min length of exist-
ing informal acute language measures and allow adaption to
varying contexts, the Brisbane EBLT dataset was divided to create
four Short Tests (15–25min each).
Each Brisbane EBLT Short Test assesses language across the
domains of verbal expression, auditory comprehension, reading
and writing yet focuses on a particular severity level (mild, moder-
ate or severe). Two Short Tests focus on severe language deficits:
1) “Foundation Test I” (with objects) (cup, spoon, pen and knife)
and 2) “Foundation Test II” (requiring nil objects). The “Standard
Test” examines moderate deficits and the “High Level Test” identi-
fies mild/nil impairment. Assessment items from the full Brisbane
EBLT were broadly allocated to a Short Test according to the per-
centage of participants who answered each question correctly
(>75% for the Foundation Tests, 75–35% for the Standard Test
and >45% for the High Level Test). Based on clinician feedback
some questions were included within two test versions (e.g.,
Picture Description is within the Standard and High Level Tests).
Short Test subtests are listed in Table 2.
To ensure clinical applicability of these new shorter measures,
all Short Test underwent acute hospital piloting and speech path-
ology feedback to ensure the tests were effective in real-world
clinical contexts. Diagnostic analysis was separately completed for
all Short Tests allowing each to act as standalone assessments
enabling clinicians to select any test version at their discretion
based on their initial clinical impression, the context, the presence
of any co-occurring deficits and level of language functioning
they wish to assess (thereby preventing patients from being
exposed to tasks markedly too simple/difficult). The same scoring
method applies to all test versions where each question is attrib-
uted a score adding to a total score used to indicate the presence
of aphasia. Full scoring instructions are available at
brisbanetest.org.
Adapted test scores
Additional subdivision of the Brisbane EBLT datasets was con-
ducted to create adapted test scores. Adapted scores enable the
tests to be administered and total scores calculated despite the
elimination of certain subtests which may be required depending
upon different testing environments. The full Brisbane EBLT and
Short Tests (excluding High Level) have adapted test versions to
adjust to the context (e.g., limited time), patient ability (e.g.,
fatigue) or when severe co-occurring conditions are present (e.g.,
hemiparesis, hemianopia, dysarthria or apraxia of speech). The full
Brisbane EBLT has two adapted scores. The first excludes the
Table 1. Continued.
Subtest Task description Score Total
47. Written Naming – Gesture “Watch what I am doing, and then write it down” (clapping). /1
48. Sentence Construction “Write one sentence which contains all of these words” /13
49. Self-Reported Difficulty? “Do you think you found it harder than you would have before
your stroke?”
Yes/No /29
Total Brisbane EBLT Score: /258
Adapted score: excluding hospital ward itemsb /254
Adapted score: excluding verbal expression subtestsc /105
aRequires everyday objects. Test items require two of each of the following everyday objects (cup, spoon, pen and knife).
bAdapted score: excluding hospital ward items. Enables the test to be administered in a clinic or non-hospital ward location. Total score is calculated by omitting
the subtest requiring the naming of hospital ward objects (bed, pillow etc).
cAdapted score: excluding verbal expression subtests. Enables the test to be administered with patients with co-occurring expressive deficits affecting their verbal
responses (e.g., apraxia of speech). Total score is calculated by omitting the Verbal Expression section (subtests 15–29) & Delayed Recall (subtest 39) and summing
performance from the remaining four modalities (auditory comprehension, perception, reading and writing).
dScore of/45 and/35 are maximum possible scores only (not cut-off scores). High maximum scores of/45 and/35 were selected to minimise the likelihood any patient
will achieve them and consequently all patient responses are captured in the test total.
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subtest requiring the naming of hospital ward objects (e.g., bed,
pillow) and enables the test to be administered in a clinic room
(the Foundation Tests and Standard Test also have this adapted
version). The second adapted version allows the calculation of a
total score while excluding subtests which rely heavily upon ver-
bal expression as the mode of patient response. Excluding these
subtests minimises the confounding of the overall total test scores
by the presence of severe co-occurring dysarthria or apraxia of
speech. The Standard Test has an additional adapted score which
excludes reading and writing tasks and enables the test to be
administered when there is limited time, patient fatigue or when
there are severe co-occurring deficits affecting reading (e.g., hemi-
anopia) and/or written responses (e.g., hemiparesis). Note, any
dysgraphia and dyslexia will not be identified using this adapted
score. Diagnostic analysis was completed for all adapted test
scores. Brisbane EBLT adapted scores are reported in Table 1 and
Short Tests adapted scores in Table 2.
Indeterminate Brisbane EBLT and reference standard results
The Brisbane EBLT was developed with the aim to minimise the
influence of non-language related deficits (e.g., hemiparesis, hemi-
anopia, apraxia of speech) on language test scores, however
when co-occurring deficits were severe (e.g., hemiparesis which
prevented the completion of any writing tasks) affected test
scores were recorded as missing and scored zero to ensure result-
ant scores were as pragmatic and reflective of clinical practice as
possible. Reference standard tests were scored according to man-
ual instructions. If reference standard data was missing or
impaired due to non-language deficits, subtest scores were used
instead. For all participants, multiple factors informed reference
standard diagnosis.
Results
Participants
Of 154 eligible admissions, 120 (77.9%) stroke patients consented
to participate. Of these, 100 (64.9%) completed both assessments
(Figure 1). Cognition was not screened or assessed formally or
informally but rather the participants’ successful engagement in
and completion of the assessment process made them eligible to
participate and have their data used in the protocol. The flow-
chart of study eligibility and recruitment is provided in Figure 1.
Participant characteristics (patients who completed both assess-
ments) are described in Table 3.
To optimise test external validity, common post-stroke co-
occurring conditions were not used as exclusion criteria. Patients
with non-language but communication-related co-occurring con-
ditions (affecting vision, hearing, speaking, or writing) were
included within the study sample. The Brisbane EBLT was devel-
oped to minimise the impact of these conditions (e.g., large
stimulus/text size) with the specific aim of enabling the majority
of patients to complete assessment items. This test design was
found to be able to accommodate the majority of co-occurring
conditions, enabling patients who presented with mild or moder-
ate co-occurring deficits (e.g., mild-moderate hemiparesis) to still
perform set tasks and questions. However, a limited number of
patients who presented with severe co-occurring conditions (e.g.,
severe hemiparesis) were still unable to complete certain Brisbane
EBLT assessment items. The percentage of included patients pre-
senting with co-occurring conditions and the number of patients
unable to complete certain tasks due to the severity of their
impairment (reported in brackets) were: hearing impairment 43%
n¼ 43 (0 patients) (i.e., 43 (43%) patients reported some form of
hearing impairment however all of these deficits were able to be
overcome (e.g., repetition of instructions/increasing volume) in all
cases such that 0 patients were unable to complete items due to
the severity of their hearing deficits); hemianopia 27.06% n¼ 26
(4 patients); hemiparesis 60% n¼ 60 (8 patients); upper limb
apraxia 5%; n¼ 5 (1 patient); apraxia of speech 25% n¼ 24 (13
patients); and dysarthria 34% n¼ 34 (4 patients).
Statistically, the inclusion of patients with severe co-occurring
conditions had little impact on the overall psychometric dataset.
When patients had severe deficits in one area (e.g., severe hemi-
paresis resulting in inability to write), these patients were often
able to complete items in other areas (e.g., verbal tasks such as
following commands). As a result, the overall impact of these
affected test items was found to constitute <5% of the recorded
data and consequently the impact of missing data was considered
statistically negligible [24]. In clinical practice however, when
patient performance needs to be summed to calculate an overall
test score, the creation of Brisbane EBLT Adapted Test Scores
assists with further adjusting the test to accommodate the pres-
ence of these severe co-occurring conditions.
Distribution of severity of language impairment
Seventy-three (73%) participants were diagnosed with aphasia
according to the reference standard. Of these, seven were
assessed using the AST [22] (severe aphasia), 36 with the CAT [9]
(moderate aphasia), and 57 with the MCLA [23] (mild or nil apha-
sia). The Brisbane EBLT demonstrated no floor or ceiling effects
with scores ranging from 7 to 215 (out of a possible 0 to 258)
(Figure 2).
Time interval between index test and reference standard
Patients were admitted to hospital on average 1 day 14 h post-
stroke. The average time between admission and completion of
both assessments was 7 days 3.75 h (ranging from 1day 21 h to
28 days 6 h). The Brisbane EBLT took 48.09min and the reference
standard took 76.05min on average to complete. The average
time between assessments was 23 h 39min. Patients received
only dysphagia related speech pathology intervention between
the two tests.
Adverse events from performing the index test or
reference standard
Patients reported fatigue when completing the reference stand-
ard. In the absence of an existing recognised acute diagnostic lan-
guage test, the reference battery was lengthy (average 76.05min)
and consequently not optimal for acute use [2,11].
Estimates of diagnostic accuracy
Brisbane EBLT
An overall Brisbane EBLT cut-off score of 157 had a sensitivity of
80.8% (95% CI, 69.9–89.1) and specificity of 92.6% (95% CI,
75.7–99.1) with LRþ 10.9 and LR 0.21. ROC analysis indicated an
AUC of 0.908 (SE 0.030) (95% CI, 0.85–0.97). Threshold scores indi-
cating presence of language impairment were determined based
on the cut-off that yielded the highest sensitivity for a specificity
90%. Score distributions indicated that aphasia diagnosis repre-
sented a spectrum ranging from mild to severe while scores of
language-intact stroke patients clustered in a narrower range thus
creating a shoulder effect for specificity. Cut-off score distribution
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analysis indicated that despite the lower sensitivity estimates
(80.8%) obtained from this cut-off, patients diagnosed with
aphasia who achieved Brisbane EBLT scores of 157 documented
a similar score range to those without language impairment
(Figure 3). In circumstances when a single (binary) cut-off score
may be needed (e.g., for research), these lower cut-off thresholds
should be used. However, to assist with clinical exclusion of the
condition, threshold scores above which indicate likely absence of
impairment were also determined based on higher cut-offs (e.g.,
 177 (178)) that yielded sensitivities  90%. Scores between
the two cut-offs indicated possible risk of impairment. Age, edu-
cation level, and gender were not found to significantly affect test
scores. Cross tabulation of Brisbane EBLT scores by reference
standard and diagnostic accuracy estimates (including adapted
scores) are listed in Table 4.
Short Tests
Short Test versions all reported specificities of 92.6% with the
Standard and High Level Tests reporting sensitivities of 72.6%
(excluding adapted scores). Foundation Tests reported lower
Figure 1. Flowchart of patient eligibility and recruitment.
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sensitivity estimates of 57.5% given their focus on more severe
conditions. ROC analysis indicated an AUC of 0.808 (SE 0.041)
(95% CI, 0.73–0.89) for all Short Tests (Table 4). Diagnostically, the
High Level Test reported the highest estimates of the Short Tests,
equal to the full Brisbane EBLT with a sensitivity of 80.8% (95% CI
69.9–89.1) and specificity of 92.6% (95% CI 75.7–99.1).
Discussion
This multicentre cross-sectional study describes the development
and diagnostic validation of the Brisbane EBLT. The use of EBP
[15] in guiding test development aims to ensure the test meets
high psychometric standards and is feasible, user-friendly and
adaptable to varying clinical contexts, patient abilities and set-
tings. The Brisbane EBLT demonstrates good sensitivity of 80.8%
(95% CI, 69.9–89.1) and a high specificity of 92.6% (95% CI,
75.7–99.1) in identifying aphasia.
Clinically, the 15–25min Short Tests are most appropriate for
use in acute hospital use. Diagnostically, all five test versions (the
full Brisbane EBLT and four Short Tests) demonstrate specificity of
90% (excluding adapted scores). Of these, the High Level Test
reports the highest diagnostic estimates, equivalent to that of the
full Brisbane EBLT.
Comparison with other research, implications for practice,
intended use, and clinical role of the test
A wide range of language measures currently exist to aid in the
clinical assessment of aphasia [2]. A number of brief aphasia
tests such as the LAST [7] and Quick Aphasia Battery (QAB) [25]
report sensitivity and specificity data in stroke populations.
While these tests aim to quickly and efficiently assess language
functioning in the acute post-stroke environment, these brief
tests are either intended for “non-specialist” screening and/or
lack assessment across all core language domains of auditory
comprehension, verbal expression, reading comprehension and
writing [7,25]. Other measures such as the WAB-R [3], CAT [9]
and MCLA [23] provide a thorough assessment of language
however these measures have been reported to be too lengthy
for use in certain clinical contexts [2]. While these tests report
published psychometric data, surprisingly, a systematic review
examining these tests’ psychometrics was unable to identify
published diagnostic (sensitivity/specificity) validation data veri-
fying these tests’ abilities to identify aphasia in stroke popula-
tions [14].
The Brisbane EBLT aims to provide a time-efficient, compre-
hensive language test which assesses language across the severity
spectrum in all language domains, is adaptable to varying clinical
contexts and presents quick, evidence-based guidance regarding
the need for intervention. As diagnostic analysis has been com-
pleted for all five tests, each version acts as a standalone assess-
ment capable of identifying aphasia at the patient’s hospital
bedside or clinic room in as little as 15–25min. Adapted test
scores further accommodate the needs of the patient and clinical
context, enabling diagnostic estimates to be calculated despite
the presence of fatigue or common co-occurring post-stoke con-
ditions. This test aims to contribute to the accuracy and evidence-
base of aphasia assessment procedures.
Strengths and limitations
A strength of this validation study is in the methodology used.
Study participants were a consecutive sample which met a priori
sample size calculation requirements. The study employed a
Table 3. Patient sample demographics.
Characteristic Patient sample demographic (n¼ 100)
Age 66.49 years (SD 15.06) (range 26–97 years)
Education 11.58 years (SD 3.149)
(school and tertiary formal education only)
Sex Males 57% (57)
Females 43% (43)
Language Monolingual (English) 84% (84)
Bi or multilingual 16% (16)
Handedness Right 86% (86)
Left 8% (8)
Ambidextrous 6% (6)
Average time between
stroke onset and
completion of both
assessments
7 days 3.75 hours
(range 1 day 21 h–28 days 6 h)
Stroke Type Infarct 85% (85)
 17 thrombolysis
 4 clot retrieval
 3 both clot retrieval and thrombolysis
Haemorrhagic 10% (10)
Haemorrhagic and infarct 5% (5)a
aOne patient had haemorrhagic transformation post lysis.
Figure 2. Distribution of severity of language impairment ranked by Brisbane EBLT score.
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robust reference standard which used multiple clinical factors to
inform the diagnostic decision [21]. Finally, the index test and ref-
erence measure were randomized in order of administration and
test administrators were blinded to the results of the other meas-
ure. This study aims to comply with recognised published STARD
diagnostic reporting standards [18].
Different test versions optimise the clinical utility of this assess-
ment. The shorter High Level Test and the full Brisbane EBLT
reported identical diagnostic estimates. The High Level test conse-
quently provides a short but psychometrically equivalent alternative
to the longer comprehensive test and demonstrates that increased
test length does not necessarily equate to increased diagnostic
accuracy estimates. Conversely, the full 49 subtest Brisbane EBLT
presents with no floor or ceiling effects and may be useful in a
research or clinical context where patient performance of all ability
levels can be compared across the same language measure. Adapted
test scores, which enable the test to be adjusted for co-occurring
conditions (e.g., hemianopia, apraxia of speech) provide additional
flexibility. The presence of co-morbidities was common within the
recruited sample with hemianopia, hemiparesis, hearing impairment,
upper limb apraxia, apraxia of speech and dysarthria all present
within the patient cohort. The Brisbane EBLT was specifically
designed to minimise the impact of such co-occurring conditions
(e.g., large text/stimulus items, not penalising for motor based
impairment in responses and allowing repetition of tasks to account
for deficits such as hearing impairment). As a result, less than 5% of
patient language responses were unable to be scored thus indicating
the new test’s ability to adapt to the complex and multifaceted
needs of stroke populations.
Statistical uncertainty
This study’s results need to be interpreted in the context of the
following factors. While both the High Level and full Brisbane
EBLT report the same high specificity of 92.6%, their sensitivity is
80.8% indicating the test is less accurate in excluding a language
disorder. However, comparison of aphasia patients who achieved
Brisbane EBLT score of 157 and non-aphasia study participants
indicated similar performance across the two groups. Hence, des-
pite these lower diagnostic estimates, any patients not identified
through this cut-off will have a language test performance highly
similar to the language-intact stroke group. The clinical impact of
any possible language impairment upon patient functioning is
likely to be minimal. However, given the clinical usefulness of
being able to exclude impairment, higher cut-offs have also been
provided which prioritise sensitivity 90%. Patients scoring above
these cut-offs have low probability of aphasia. Finally, given the
Foundation Tests’ focus on severe language deficits, the resultant
lower sensitivities of these measures indicate other versions of
the assessment are more suited to identifying milder language
deficits. All five Brisbane EBLT tests reported AUC results of
0.808 indicating strong overall discriminative performance.
Generalisability
This study is an initial examination of the diagnostic accuracy of
the Brisbane EBLT however the generalisability and reproducibility
of these results within practice or in similar study populations
have not yet been verified. A separate validation study in a
Figure 3. Brisbane EBLT score by language diagnosis.
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similar, independent population would demonstrate the test’s
capabilities in comparable settings and enable a diagnostic sys-
tematic review and meta-analyses to be performed.
Conclusion
The Brisbane EBLT aims to provide a new language test to assist
in the identification of aphasia. The test examines patient func-
tioning across the severity spectrum in all language domains with
Short Tests capable of identifying aphasia in just 15–25min. As
diagnostic estimates have been calculated for all test versions,
each can act as a stand-alone assessment with different versions
able to adjust to the needs of varying clinical environments and
enable clinicians to select tests at their own discretion based on
patient ability and the clinical context. These findings aim to
improve the evidence-base of aphasia assessment procedures and
assist with informing accurate aphasia epidemiological statistics,
healthcare services, and developers of stroke guidelines. The
Brisbane EBLT is available for download from brisbanetest.org.
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